Rosacea, a characteristic inflammatory condition affects the skin especially the face resulting in facial erythema or redness. Around one in 10 people in the world is affected by rosacea. The condition can be controlled differently; however, there is no standard cure for the disease. The treatment also varies with the subtype of rosacea. The treatment is prescribed according to the dominant features of the disease.
To meet the unmet needs some of the key pharma players such as Foamix Pharmaceuticals, Sol-Gel Technologies, Accuitis, Hovione, Afecta Pharmaceuticals, and AOBiome Therapeutics are involved in developing novel therapies for the rosacea.
For more detailed information, visit:
https://www.delveinsight.com/blog/rosacea-treatment-market/